- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
CD19 antibody recognizes CD19, a B cell-specific type I transmembrane glycoprotein that functions as a critical coreceptor in B cell receptor signaling. CD19 is a member of the immunoglobulin superfamily and is expressed from the early pro-B cell stage through mature peripheral B lymphocytes, where it localizes to the plasma membrane. By forming a signaling complex with CD21, CD81, and CD225, CD19 amplifies antigen receptor-mediated signaling and lowers the threshold for B cell activation. Recombinant CD19 Antibody Microarray Validated is designed for consistent detection of CD19 in high-throughput tissue microarray platforms and other research applications requiring reproducible performance.
The CD19 gene is located on chromosome 16p11.2 and encodes a protein containing two extracellular immunoglobulin-like domains, a single transmembrane segment, and a cytoplasmic tail enriched in tyrosine residues that become phosphorylated upon activation. Through recruitment of signaling molecules such as PI3K, CD19 contributes to downstream pathways controlling B cell proliferation, differentiation, and survival. Recombinant CD19 Antibody Microarray Validated supports investigations into normal B cell development as well as dysregulated signaling in disease states.
In normal human tissues, CD19 expression is restricted to B lineage cells within bone marrow, lymph node, tonsil, and spleen. Terminally differentiated plasma cells typically exhibit reduced or absent CD19 expression, reflecting changes during late-stage B cell maturation. Because of this lineage specificity, CD19 serves as a reliable pan-B cell marker in immunologic research and translational studies.
Aberrant CD19 expression is characteristic of most B cell malignancies, including B cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and numerous non-Hodgkin lymphomas. CD19 has also emerged as a major therapeutic target in immunotherapy strategies, including chimeric antigen receptor T cell approaches. Accurate detection of CD19 is therefore important for studies of tumor biology, immune targeting, and treatment response.
Clone CD19/4260R is a recombinant rabbit monoclonal antibody engineered for high specificity and lot-to-lot consistency. Recombinant production ensures defined sequence identity and stable performance across experimental batches. Recombinant CD19 Antibody Microarray Validated clone CD19/4260R produces strong membranous staining in CD19-positive B cells with minimal background in non-B cell populations, making it well suited for research applications that require precise and reproducible antigen detection.
Optimal dilution of the recombinant CD19 antibody should be determined by the researcher.
A recombinant fragment of human CD19 protein (around aa1-300) was used as the immunogen for the recombinant CD19 antibody.
Aliquot the recombinant CD19 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.